System for secure mobile healthcare selection

• US 7,917,438 B2
• Filed: 09/10/2008
• Issued: 03/29/2011
• Est. Priority Date: 09/10/2008
• Status: Active Grant

• Current Assignee: 23andme Incorporated (23andMe Holding Co.)
• Original Assignee: Expanse Networks, Inc.
• Inventors: Eldering, Charles Anthony, Kenedy, Andrew Alexander
• Primary Examiner(s): Elisca; Pierre E
• Application Number:
  US12/207,720
• Publication Number:
  US 20100063930A1
• Time in Patent Office: 930 Days
• Field of Search: 705/51, 705/64, 705/67
• US Class Current: 705/51
• CPC Class Codes: G06Q 20/3674 involving authentication
• CPC Class Codes: G06Q 20/382 insuring higher security of transaction
• CPC Class Codes: G06Q 30/02 Marketing; Price estimation or determination; Fundraising
• CPC Class Codes: G06Q 30/08 Auctions
• CPC Class Codes: G16H 10/40 for data related to laboratory analysis, e.g. patient specimen analysis
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records

Abstract

A method, system and device for secure mobile healthcare selection are presented in which a user can, from a mobile device, authorize the comparison of pangenetic (genetic and epigenetic) data with data profiles corresponding to healthcare products, services and service providers to determine which are the most appropriate for a particular consumer. Data masking is used to maintain privacy of sensitive portions of the pangenetic data.

Claims

1. A mobile device and second computer system for determining a user'"'"'s likely success for disease treatment from a treatment provider by providing access to masked pangenetic data of said user to said second computer system and enabling said user to accept or reject a treatment provider, comprising:

a) a mobile receiver receiving a request from said second computer system requiring access to pangenetic data of said user stored on said mobile device;

b) an authorization interface actuated by said user granting access to the pangenetic data by generating an authorization associated with at least one pre-approved data mask; and

c) a transmitter transmitting the authorization associated with the at least one pre-approved data mask to said second computer system and transmitting said pangentic data to said second computer; and

,

d) said second computer system conducting a comparative assessment of said user transmitted pangenetic data with previously stored treatment provider related data on said second computer system to determine likely outcomes or success rates of said user with said treatment provider and providing said success rates to said user based on prior success rates of treatment of prior users of said treatment with correlated degrees of pangentic data match of said user.

2. The mobile device of claim 1, wherein the authorization interface generates the authorization if supplied with user input comprising at least one combination of characters that matches at least one combination of characters previously stored in association with the user, each of the characters being selected from the group consisting of alphanumeric characters and non-alphanumeric characters.

3. The mobile device of claim 1, wherein the authorization interface generates the authorization if supplied with user input comprising at least one combination of characters that matches at least one combination of characters randomly selected by software that interacts with the authorization interface, each of the characters being selected from the group consisting of alphanumeric characters and non-alphanumeric characters.

4. The mobile device of claim 1, wherein the authorization interface generates the authorization if supplied with user input comprising biometric data that matches biometric data previously stored in association with the user.

5. The mobile device of claim 1, wherein said second computer system comprises at least one of a database, a dataset, a computer readable memory, a computer readable medium, a computer processor, a computer network, a printout device, a visual display, and a wireless receiver.

6. The mobile device of claim 1, wherein the pangenetic data are selected from the group consisting of single nucleotide polymorphisms, nucleotides, base pairs, nucleotide sequences, gene sequences, genomic sequences, gene mutations, epigenetic modifications, epigenetic sequence patterns, and pangenetic based disorders, traits and conditions.

7. A computer based method for providing access to masked data of a user in a mobile environment to provide said user with data as to the likelyhood of a useful therapeutic relationship being possible with respect to said user and a therapy provider, comprising:

a) receiving by a mobile computer or processor a request from a second computer having therapy data stored therein requiring access to pangenetic data of said user stored on said mobile computer or processor;

b) generating an authorization initiated by said user associated with at least one pre-approved data mask specified by said user to grant access to the pangenetic data by said second computer;

c) transmitting the authorization associated with the at least one pre-approved data mask to said second computer; and

,

d) said second computer system conducting a comparative assessment of said user transmitted pangenetic data with previously stored treatment provider related data on said second computer system to determine likely outcomes or success rates of said user with said treatment provider and providing said success rates to said user based on prior success rates of treatment of prior users of said treatment having correlated degrees of pangentic data match with said user.

8. The computer based method of claim 7, wherein, in order for the authorization to be generated, a user is required to supply input comprising at least one combination of characters that matches at least one combination of characters previously stored in association with the user, each of the characters being selected from the group consisting of alphanumeric characters and non-alphanumeric characters.

9. The computer based method of claim 7, wherein, in order for the authorization to be generated, a user is required to supply input comprising at least one combination of characters that matches at least one combination of characters randomly selected by software interacting with the authorization interface, each of the characters being selected from the group consisting of alphanumeric characters and non-alphanumeric characters.

10. The computer based method of claim 7, wherein, in order for the authorization to be generated, a user is required to supply input comprising biometric data that matches biometric data previously stored in association with the user.

11. The computer based method of claim 7, wherein the said second computer is selected from the group consisting of, a database, a dataset, a computer readable memory, a computer readable medium, a computer processor, a computer network, a printout device, a visual display, and a wireless receiver.

12. The computer based method of claim 7, wherein the pangenetic data are selected from the group consisting of single nucleotide polymorphisms, nucleotides, base pairs, nucleotide sequences, gene sequences, genomic sequences, gene mutations, epigenetic modifications, epigenetic sequence patterns, and pangenetic based disorders, traits and conditions.

13. A computer system for providing access to a user'"'"'s masked pangenetic data in a mobile environment and providing that data to a second computer so as to generate information transmitted to said user regarding a likely successful outcome for treatments provided by a disease treatment provider, comprising:

a) a mobile receiving module receiving a request requiring access to said user'"'"'s pangenetic data;

b) an authorization module establishing a secure connection with said mobile device and for verifying the identity of a user of the mobile device; and

c) a communications module authorizing transmission of pangenetic data to said second computer to which a data mask has been applied based on the request and the verified identity of the user of the mobile device; and

,

d) said second computer system conducting a comparative assessment of said user transmitted pangenetic data with previously stored treatment provider related data on said second computer system to determine likely outcomes or success rates of said user with said treatment provider and providing said success rates to said user based on prior success rates of treatment of prior receivers of said treatment having correlated degrees of pangentic data match with said user.

14. The computer system of claim 13, further comprising a data mask selection module for selecting the data mask for application to the pangenetic data based on the request and the verified identity of the user of the mobile device.

15. The computer system of claim 13, further comprising a data mask application module for applying the data mask to the pangenetic data based on the request and the verified identity of the user of the mobile device.

16. The computer system of claim 13, wherein the authorization module also verifies application of the data mask to the pangenetic data.

17. The computer system of claim 13, wherein application of the data mask to the pangenetic data conceals one or more pangenetic features associated with one or more health conditions.

18. The computer system of claim 13, wherein application of the data mask to the pangenetic data conceals one or more pangenetic features associated with one or more disease predispositions.

19. The computer system of claim 13, wherein the pangenetic data are selected from the group consisting of single nucleotide polymorphisms, nucleotides, base pairs, nucleotide sequences, gene sequences, genomic sequences, gene mutations, epigenetic modifications, epigenetic sequence patterns, and pangenetic based disorders, traits and conditions.

20. A computer based method including at least a mobile device and second computer for providing access by said second computer to masked pangenetic data regarding a user for determining a likelihood of a successful outcome for disease treatment provided by a treatment provider based on a comparative analysis performed by said second computer on said pangenetic data of said user stored on said mobile device and data of past treatment outcomes stored on said second computer, comprising:

a) receiving by a mobile computer or processor device a request from said second computer requiring access to pangenetic data of a user stored on said mobile device;

b) establishing a secure connection between said mobile device and said second computer;

c) verifying the identity of a user of the mobile device; and

d) authorizing transmission of pangenetic data to which a data mask has been applied based on the request and the verified identity of the user of the mobile device; and

,

e) said second computer system conducting a comparative assessment of said user transmitted pangenetic data with previously stored treatment provider related data on said second computer system to determine likely outcomes or success rates of said user with said treatment provider and providing said success rates to said user, said success rates being based on prior success of said treatment to prior receivers of said treatment with correlated degrees of pangentic data match to said user.

21. The computer based method of claim 20, further comprising a step of selecting the data mask for application to the pangenetic data based on the request and the verified identity of the user of the mobile device.

22. The computer based method of claim 20, further comprising a step of applying the data mask to the pangenetic data based on the request and the verified identity of the user of the mobile device.

23. The computer based method of claim 20, further comprising verifying the application of the data mask to the pangenetic data.

24. The computer based method of claim 20, wherein application of the data mask to the pangenetic data conceals one or more pangenetic features associated with one or more health conditions.

25. The computer based method of claim 20, wherein application of the data mask to the pangenetic data conceals one or more pangenetic features associated with one or more disease predispositions.

26. The computer based method of claim 20, wherein verifying the identity of the user of the mobile device comprises i) receiving at least one combination of characters input by the user and ii) determining whether the at least one combination of characters input by the user matches at least one combination of characters previously stored in association with the user, each of the characters being selected from the group consisting of alphanumeric characters and non-alphanumeric characters.

27. The computer based method of claim 20, wherein verifying the identity of the user of the mobile device comprises i) receiving at least one combination of characters input by the user and ii) determining whether the at least one combination of characters input by the user matches at least one combination of characters randomly selected by software that interacts with the authorization interface, each of the characters being selected from the group consisting of alphanumeric characters and non-alphanumeric characters.

28. The computer based method of claim 20, wherein verifying the identity of the user of the mobile device comprises i) receiving biometric data input by the user and ii) determining whether the biometric data input by the user matches biometric data previously stored in association with the user.

29. The computer based method of claim 20, wherein the pangenetic data are selected from the group consisting of single nucleotide polymorphisms, nucleotides, base pairs, nucleotide sequences, gene sequences, genomic sequences, gene mutations, epigenetic modifications, epigenetic sequence patterns, and pangenetic based disorders, traits and conditions.